Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diet | 5 | 2023 | 801 | 1.560 |
Why?
|
Health Status Disparities | 2 | 2021 | 642 | 0.950 |
Why?
|
Food | 1 | 2023 | 100 | 0.850 |
Why?
|
Fatty Liver | 2 | 2021 | 64 | 0.850 |
Why?
|
Nutrition Assessment | 1 | 2023 | 79 | 0.850 |
Why?
|
Databases, Factual | 5 | 2020 | 291 | 0.840 |
Why?
|
Accidents, Traffic | 2 | 2020 | 42 | 0.820 |
Why?
|
United States | 16 | 2023 | 4223 | 0.780 |
Why?
|
Head Protective Devices | 1 | 2019 | 9 | 0.700 |
Why?
|
Neck Injuries | 1 | 2019 | 10 | 0.700 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 19 | 0.700 |
Why?
|
Bicycling | 1 | 2019 | 17 | 0.690 |
Why?
|
Injury Severity Score | 1 | 2019 | 61 | 0.690 |
Why?
|
Mexican Americans | 1 | 2021 | 189 | 0.680 |
Why?
|
Wounds and Injuries | 1 | 2020 | 161 | 0.640 |
Why?
|
Hospital Mortality | 2 | 2019 | 187 | 0.620 |
Why?
|
Humans | 43 | 2024 | 37093 | 0.590 |
Why?
|
Pancreatitis | 2 | 2007 | 17 | 0.560 |
Why?
|
Dementia, Vascular | 1 | 2016 | 36 | 0.530 |
Why?
|
Adult | 25 | 2023 | 11712 | 0.530 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2021 | 643 | 0.520 |
Why?
|
Inpatients | 1 | 2016 | 74 | 0.510 |
Why?
|
Middle Aged | 23 | 2023 | 10129 | 0.500 |
Why?
|
Male | 31 | 2024 | 20025 | 0.500 |
Why?
|
Aged | 19 | 2023 | 6741 | 0.490 |
Why?
|
Female | 31 | 2024 | 20969 | 0.490 |
Why?
|
Dementia | 1 | 2015 | 131 | 0.480 |
Why?
|
Nutrition Surveys | 5 | 2021 | 242 | 0.460 |
Why?
|
Diabetes Mellitus | 3 | 2016 | 485 | 0.460 |
Why?
|
Aged, 80 and over | 11 | 2016 | 2379 | 0.450 |
Why?
|
Young Adult | 9 | 2021 | 4268 | 0.430 |
Why?
|
Gastrointestinal Diseases | 2 | 2003 | 42 | 0.420 |
Why?
|
Treatment Outcome | 4 | 2020 | 1369 | 0.410 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2003 | 121 | 0.410 |
Why?
|
Adolescent | 13 | 2024 | 5363 | 0.400 |
Why?
|
Prevalence | 5 | 2021 | 1455 | 0.350 |
Why?
|
Alzheimer Disease | 1 | 2016 | 905 | 0.320 |
Why?
|
Risk Factors | 8 | 2023 | 3562 | 0.320 |
Why?
|
Multiple Organ Failure | 1 | 2007 | 7 | 0.310 |
Why?
|
Jaundice | 1 | 2007 | 7 | 0.310 |
Why?
|
Hospitalization | 4 | 2015 | 388 | 0.310 |
Why?
|
Proton Pump Inhibitors | 1 | 2007 | 9 | 0.300 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2007 | 7 | 0.300 |
Why?
|
Albuminuria | 2 | 2020 | 76 | 0.290 |
Why?
|
Cross Infection | 1 | 2007 | 38 | 0.290 |
Why?
|
Diarrhea | 1 | 2007 | 89 | 0.280 |
Why?
|
Comorbidity | 3 | 2016 | 623 | 0.280 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2007 | 215 | 0.260 |
Why?
|
Hepatitis C | 1 | 2006 | 125 | 0.250 |
Why?
|
Retrospective Studies | 6 | 2023 | 2026 | 0.250 |
Why?
|
Dyspepsia | 1 | 2004 | 5 | 0.240 |
Why?
|
Neurosecretory Systems | 1 | 2024 | 16 | 0.240 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 7 | 0.230 |
Why?
|
Elasticity Imaging Techniques | 1 | 2023 | 9 | 0.230 |
Why?
|
Healthcare Disparities | 2 | 2023 | 494 | 0.230 |
Why?
|
Geriatric Assessment | 1 | 2023 | 51 | 0.220 |
Why?
|
Psychotic Disorders | 1 | 2023 | 55 | 0.210 |
Why?
|
Regression Analysis | 2 | 2021 | 455 | 0.210 |
Why?
|
Cultural Diversity | 2 | 2019 | 169 | 0.210 |
Why?
|
Veterans | 1 | 2023 | 122 | 0.210 |
Why?
|
Sex Characteristics | 1 | 2024 | 230 | 0.210 |
Why?
|
Eating | 1 | 2023 | 166 | 0.200 |
Why?
|
Chronic Disease | 2 | 2023 | 484 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2023 | 864 | 0.190 |
Why?
|
Population Surveillance | 3 | 2017 | 238 | 0.190 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 2721 | 0.180 |
Why?
|
Curcumin | 1 | 2020 | 74 | 0.180 |
Why?
|
C-Reactive Protein | 1 | 2020 | 149 | 0.170 |
Why?
|
Age Distribution | 1 | 2020 | 225 | 0.170 |
Why?
|
Inflammation Mediators | 1 | 2020 | 123 | 0.170 |
Why?
|
Education | 1 | 2019 | 55 | 0.170 |
Why?
|
Physicians | 1 | 2021 | 163 | 0.170 |
Why?
|
Trauma Centers | 1 | 2019 | 79 | 0.170 |
Why?
|
Erectile Dysfunction | 1 | 2019 | 38 | 0.160 |
Why?
|
Sex Distribution | 2 | 2017 | 215 | 0.160 |
Why?
|
Child | 5 | 2021 | 3131 | 0.160 |
Why?
|
Research Personnel | 1 | 2019 | 155 | 0.160 |
Why?
|
Los Angeles | 4 | 2010 | 380 | 0.160 |
Why?
|
Stress, Psychological | 1 | 2024 | 583 | 0.150 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 208 | 0.150 |
Why?
|
Exercise | 1 | 2023 | 613 | 0.150 |
Why?
|
Biomedical Research | 2 | 2019 | 400 | 0.140 |
Why?
|
Substance-Related Disorders | 1 | 2024 | 730 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 155 | 0.140 |
Why?
|
Acute Disease | 2 | 2007 | 147 | 0.140 |
Why?
|
Insulin Resistance | 1 | 2017 | 184 | 0.130 |
Why?
|
Depression | 2 | 2016 | 712 | 0.120 |
Why?
|
Cartoons as Topic | 1 | 2014 | 3 | 0.120 |
Why?
|
Minority Groups | 1 | 2019 | 596 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 12 | 0.120 |
Why?
|
Cognition | 1 | 2017 | 398 | 0.120 |
Why?
|
Shock, Septic | 1 | 2014 | 20 | 0.120 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 26 | 0.120 |
Why?
|
Empathy | 1 | 2013 | 28 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2014 | 90 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 803 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2003 | 27 | 0.110 |
Why?
|
California | 5 | 2014 | 476 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2014 | 215 | 0.100 |
Why?
|
Stroke | 1 | 2016 | 286 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2023 | 1130 | 0.100 |
Why?
|
Health Literacy | 1 | 2014 | 105 | 0.100 |
Why?
|
Brain Injuries | 1 | 2013 | 121 | 0.100 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 233 | 0.100 |
Why?
|
Pyrazines | 1 | 2011 | 24 | 0.100 |
Why?
|
Thiazolidinediones | 1 | 2011 | 50 | 0.100 |
Why?
|
Triazoles | 1 | 2011 | 86 | 0.090 |
Why?
|
Sunburn | 1 | 2010 | 4 | 0.090 |
Why?
|
Xylans | 1 | 2010 | 23 | 0.090 |
Why?
|
Sunlight | 1 | 2010 | 47 | 0.090 |
Why?
|
Nicotine | 1 | 2012 | 257 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 160 | 0.090 |
Why?
|
Patient Discharge | 2 | 2007 | 93 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2011 | 560 | 0.080 |
Why?
|
Parenting | 1 | 2010 | 127 | 0.080 |
Why?
|
Hypertension | 1 | 2016 | 796 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 145 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2010 | 190 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2007 | 18 | 0.080 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2007 | 41 | 0.080 |
Why?
|
Odds Ratio | 2 | 2014 | 534 | 0.070 |
Why?
|
Databases as Topic | 1 | 2007 | 20 | 0.070 |
Why?
|
Hypoglycemia | 1 | 2007 | 17 | 0.070 |
Why?
|
Health Education | 1 | 2010 | 338 | 0.070 |
Why?
|
Colonic Diseases | 1 | 2006 | 11 | 0.070 |
Why?
|
Irritable Bowel Syndrome | 1 | 2006 | 9 | 0.070 |
Why?
|
Research Design | 2 | 2023 | 313 | 0.070 |
Why?
|
Adolescent Health Services | 1 | 2006 | 29 | 0.070 |
Why?
|
Liver | 2 | 2023 | 479 | 0.070 |
Why?
|
Child Health Services | 1 | 2006 | 43 | 0.070 |
Why?
|
Vision Disorders | 1 | 2006 | 58 | 0.070 |
Why?
|
Colon | 1 | 2006 | 103 | 0.070 |
Why?
|
Prospective Studies | 2 | 2023 | 1378 | 0.060 |
Why?
|
Focus Groups | 2 | 2019 | 348 | 0.060 |
Why?
|
Program Evaluation | 2 | 2021 | 339 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2006 | 103 | 0.060 |
Why?
|
Pregnancy, Ectopic | 1 | 2005 | 14 | 0.060 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2004 | 2 | 0.060 |
Why?
|
Gallstones | 1 | 2004 | 3 | 0.060 |
Why?
|
Public Housing | 1 | 2005 | 15 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2006 | 146 | 0.060 |
Why?
|
Needs Assessment | 1 | 2006 | 170 | 0.060 |
Why?
|
Child, Preschool | 4 | 2013 | 1418 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2004 | 16 | 0.060 |
Why?
|
Hospitals, Urban | 1 | 2004 | 39 | 0.060 |
Why?
|
Hospitals, Teaching | 1 | 2004 | 27 | 0.060 |
Why?
|
Radiography | 1 | 2004 | 72 | 0.060 |
Why?
|
Pregnancy | 2 | 2006 | 1549 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 352 | 0.060 |
Why?
|
Adolescent Development | 1 | 2024 | 31 | 0.060 |
Why?
|
ROC Curve | 1 | 2023 | 138 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 52 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2005 | 126 | 0.060 |
Why?
|
Biopsy | 1 | 2023 | 164 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2023 | 66 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2023 | 75 | 0.050 |
Why?
|
Body Mass Index | 1 | 2006 | 854 | 0.050 |
Why?
|
Food Supply | 1 | 2023 | 112 | 0.050 |
Why?
|
Inflammation | 1 | 2006 | 618 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 282 | 0.050 |
Why?
|
Infant | 3 | 2013 | 1046 | 0.050 |
Why?
|
Urban Population | 1 | 2003 | 333 | 0.050 |
Why?
|
Faculty | 1 | 2021 | 94 | 0.050 |
Why?
|
Sirolimus | 1 | 2020 | 60 | 0.050 |
Why?
|
Mentors | 1 | 2021 | 127 | 0.040 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 78 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 400 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 1067 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 269 | 0.040 |
Why?
|
Quality of Life | 1 | 2023 | 481 | 0.040 |
Why?
|
Base Sequence | 1 | 2020 | 997 | 0.040 |
Why?
|
Disease Progression | 1 | 2020 | 601 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2020 | 578 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2013 | 894 | 0.040 |
Why?
|
Cause of Death | 1 | 2017 | 156 | 0.040 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 259 | 0.040 |
Why?
|
Health Surveys | 1 | 2017 | 373 | 0.030 |
Why?
|
MicroRNAs | 1 | 2020 | 426 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 807 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2020 | 1198 | 0.030 |
Why?
|
Video Recording | 1 | 2014 | 32 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 2231 | 0.030 |
Why?
|
HIV Infections | 1 | 2007 | 2303 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 139 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2013 | 66 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2012 | 30 | 0.030 |
Why?
|
Mice, Obese | 1 | 2012 | 40 | 0.030 |
Why?
|
Animal Feed | 1 | 2012 | 43 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 58 | 0.030 |
Why?
|
Hepatocytes | 1 | 2012 | 75 | 0.030 |
Why?
|
Triglycerides | 1 | 2012 | 138 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2012 | 105 | 0.030 |
Why?
|
Signal Transduction | 1 | 2020 | 1908 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 36 | 0.030 |
Why?
|
Qualitative Research | 1 | 2014 | 446 | 0.020 |
Why?
|
Psychometrics | 1 | 2013 | 318 | 0.020 |
Why?
|
Ethiodized Oil | 1 | 2010 | 3 | 0.020 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2010 | 5 | 0.020 |
Why?
|
Incidence | 1 | 2014 | 922 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2010 | 43 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2010 | 31 | 0.020 |
Why?
|
Catheter Ablation | 1 | 2010 | 30 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1033 | 0.020 |
Why?
|
Telephone | 1 | 2010 | 34 | 0.020 |
Why?
|
Program Development | 1 | 2011 | 233 | 0.020 |
Why?
|
Community-Based Participatory Research | 1 | 2014 | 317 | 0.020 |
Why?
|
Doxorubicin | 1 | 2010 | 84 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2010 | 286 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2010 | 275 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 128 | 0.020 |
Why?
|
Social Class | 1 | 2011 | 247 | 0.020 |
Why?
|
Curriculum | 1 | 2011 | 265 | 0.020 |
Why?
|
Ethanol | 1 | 2010 | 192 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2010 | 159 | 0.020 |
Why?
|
Universities | 1 | 2011 | 442 | 0.020 |
Why?
|
Pilot Projects | 1 | 2010 | 661 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 1609 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 974 | 0.020 |
Why?
|
Medical Records | 1 | 2007 | 41 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2012 | 938 | 0.020 |
Why?
|
Eyeglasses | 1 | 2006 | 21 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2006 | 136 | 0.020 |
Why?
|
Colonoscopy | 1 | 2006 | 104 | 0.020 |
Why?
|
Apoptosis | 1 | 2012 | 1398 | 0.020 |
Why?
|
Data Collection | 1 | 2005 | 194 | 0.010 |
Why?
|
Health Promotion | 1 | 2010 | 653 | 0.010 |
Why?
|
Mice | 1 | 2012 | 5913 | 0.010 |
Why?
|
Health Status | 1 | 2005 | 380 | 0.010 |
Why?
|
Animals | 1 | 2012 | 15081 | 0.010 |
Why?
|